IgG4-related disease (IgG4-RD) is a chronic, fibroinflammatory disorder defined by IgG4-rich lymphoplasmacytic, pseudotumoral infiltrates.1 Its pathogenesis – shaped by genetic susceptibility and (auto-)antigenic or environmental triggers – reflects dysregulated crosstalk between B cells/plasma cells and specialized T-cell subsets.1 The resulting immune cascade can cause aggressive inflammation and organ damage across any tissue, most commonly the pancreas, biliary tract, salivary glands, kidneys, and lungs.
Journal of Hepatology published a clinical update in Research Highlights on 14 Feb 2026.
The item focuses on Approaching the holy grail in autoimmunity: CD19 CAR T-cell therapy in multiorgan IgG4-related disease.
Review the original article for the full source wording and details.